Hantavirus vs Ebola: comparing two high-mortality viruses
Both hantavirus and Ebola have alarming case fatality rates, but they differ in transmission, geography, and outbreak dynamics.
| Metric | hantavirus | ebola |
|---|---|---|
| Pathogen family | Hantaviridae | Filoviridae |
| Primary reservoir | Rodents (species-specific) | Fruit bats (suspected); other primates |
| Human-to-human transmission | Rare (Andes only, close contact) | Yes — bodily fluids |
| Case fatality rate | 30-40% (Andes HPS) | 25-90% (Ebola Zaire 50-90%) |
| Incubation | 2-8 weeks | 2-21 days |
| Vaccine | None internationally approved | Yes — Ervebo (rVSV-ZEBOV) approved |
| Treatment | Supportive ICU only | Inmazeb / Ebanga monoclonal antibodies; supportive |
| Major outbreaks | Argentina 1996 (El Bolsón), USA 1993 (Four Corners) | West Africa 2014-16 (28k cases, 11k deaths), DRC 2018-20 |
| Pandemic history | Never | Multiple regional outbreaks; never global pandemic |
Verdict
Ebola is more transmissible between humans than hantavirus and has caused much larger outbreaks (tens of thousands of cases vs hundreds for hantavirus). Hantavirus's high CFR is offset by very limited human-to-human chains. Both are 'high consequence, low probability' threats requiring surveillance, not panic.
Sources
Last update May 7, 2026 · ⚠ Not medical advice.